Solvay: UBS still a buyer

(CercleFinance.com) - UBS reinstates its "buy" rating on the share of Belgian chemist Solvay, along with its target price of 105 euros, which represents upside potential of 20%, highlighting a "restructuring optionality" that it believes is not priced in.


"US litigation risk weighing on valuation but we also see significant upside to sentiment on 1) operating performance outlook and 2) restructuring optionality," the broker says.


Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.